Internal Medicine

3151 questions

Question 1181Question →

During a routine prenatal visit at 27 weeks gestation, a 29-year-old gravida 1, para 0 reports increasing fatigue, swelling in her lower extremities, and intermittent pain in her wrists and metacarpophalangeal joints over the past two weeks. She was diagnosed with systemic lupus erythematosus four years ago, which has been quiescent on a regimen of hydroxychloroquine. Her home blood pressure readings have trended upward to approximately 145/90 mm Hg over the last several days. Vital signs today include a temperature of 37.1 C (98.8 F), blood pressure of 152/96 mm Hg, and pulse of 84/min. Physical examination confirms 2+ pitting edema extending to the mid-calves and mild synovitis in the hands. Urinalysis demonstrates 3+ proteinuria but is negative for leukocyte esterase and nitrites. The medical team is debating whether her presentation represents a primary hypertensive disorder of pregnancy or an exacerbation of her underlying autoimmune diathesis. Which of the following laboratory findings would most strongly point toward an autoimmune exacerbation?

Show answer & explanation

Answer: Decreased serum complement levels

Answer

Decreased serum complement levels
The correct answer is decreased serum complement levels.

Both preeclampsia and a lupus nephritis flare can present with new-onset hypertension, proteinuria, and edema during pregnancy (typically after 20 weeks). Distinguishing between the two is critical because their management differs significantly.

FeatureLupus Nephritis FlarePreeclampsia
Complement (C3, C4)Decreased (consumed)Normal or increased
Anti-dsDNAOften risingNormal
Urine SedimentActive (RBCs, RBC casts)Bland
Uric AcidNormalElevated
Liver EnzymesTypically normalElevated in severe forms (HELLP)
Other SymptomsJoint pain, rash, feverHeadache, visual changes, right upper quadrant pain
In systemic lupus erythematosus (SLE), an acute disease flare involves the formation of immune complexes that rapidly consume complement, leading to hypocomplementemia. Conversely, in preeclampsia, complement proteins are usually normal or elevated as they act as acute-phase reactants. Therefore, low complement levels serve as a highly specific biomarker pointing toward an active SLE flare.

Step-by-Step Solution

1
Identify the primary differential diagnosis for new-onset hypertension and proteinuria in a pregnant patient at 27 weeks gestation with a history of systemic lupus erythematosus.
The clinical picture strongly points to a differential between preeclampsia and a lupus nephritis flare.
Both conditions can present identically in the second and third trimesters with hypertension, proteinuria, and lower extremity edema.
2
Analyze the clinical features and determine which laboratory markers can reliably differentiate between these two conditions.
Markers of an active lupus flare include decreased complement (C3, C4) and elevated anti-dsDNA. Preeclampsia is associated with normal or elevated complement, elevated uric acid, and elevated transaminases.
Identifying specific biomarkers is necessary because the fundamental clinical presentation overlaps significantly.
3
Evaluate the given options to find the specific marker that confirms an autoimmune exacerbation.
Decreased serum complement levels uniquely support an immune complex-mediated disease flare, whereas the other options either point to preeclampsia or represent baseline physiologic states.
Immune complex deposition in active systemic lupus erythematosus actively consumes complement proteins.

Key Concept

Differentiating a lupus nephritis flare from preeclampsia during pregnancy using complement levels and disease-specific biomarkers.
Question 1182Question →

A 58-year-old woman with a 10-year history of severe rheumatoid arthritis presents to the clinic with worsening fatigue over the past few months. Her joint pain has also been poorly controlled recently despite her current medication regimen. Vital signs are within normal limits. Physical examination reveals swollen, tender metacarpophalangeal and proximal interphalangeal joints bilaterally.

Laboratory studies show the following:

Laboratory TestResultReference Range
Hemoglobin10.1 g/dL12.0 - 15.5 g/dL
Mean corpuscular volume76 fL80 - 100 fL
Serum iron35 μ\mug/dL60 - 160 μ\mug/dL
Total iron-binding capacity (TIBC)210 μ\mug/dL250 - 460 μ\mug/dL
Serum ferritin520 ng/mL15 - 200 ng/mL

Which of the following is the most appropriate next step in the management of this patient's anemia?

Show answer & explanation

Answer: Optimization of rheumatoid arthritis therapy

Answer

Optimization of rheumatoid arthritis therapy
The correct answer addresses the underlying pathophysiology of this patient's condition. The patient presents with microcytic anemia and an iron profile that is classic for anemia of chronic disease (low serum iron, low TIBC, elevated ferritin). Chronic inflammation from poorly controlled rheumatoid arthritis increases the production of hepcidin in the liver. Hepcidin binds and degrades ferroportin, trapping iron inside macrophages and enterocytes. This makes iron unavailable for red blood cell production despite adequate total body stores. The definitive management for anemia of chronic disease is to treat the underlying inflammatory disease, which will subsequently lower hepcidin levels, release sequestered iron, and improve the anemia.

Step-by-Step Solution

1
Analyze the patient's complete blood count and iron panel.
The patient has a microcytic anemia with low serum iron, low total iron-binding capacity (TIBC), and elevated serum ferritin.
To differentiate between the causes of microcytic anemia, which primarily include iron deficiency anemia, anemia of chronic disease, and thalassemia.
2
Synthesize the laboratory findings with the clinical history.
The high ferritin and low TIBC in the setting of poorly controlled rheumatoid arthritis points definitively to anemia of chronic disease (also known as anemia of inflammation).
Inflammation upregulates hepcidin, leading to iron sequestration in macrophages (causing high ferritin) and decreased iron absorption, resulting in low serum iron and low TIBC.
3
Determine the best management for anemia of chronic disease.
The primary treatment is addressing the underlying inflammatory condition.
Treating the underlying rheumatoid arthritis will reduce inflammatory cytokines, decrease hepcidin levels, and restore normal iron metabolism for erythropoiesis.

Key Concept

Anemia of chronic disease (anemia of inflammation) is characterized by low serum iron, low TIBC, and normal or elevated ferritin. The definitive treatment is managing the underlying inflammatory disorder.
Estimated Time:1m 0s
Question 1183Question →

A 72-year-old man is brought to the emergency department by his daughter due to progressive lethargy, severe constipation, and deep lower back pain over the past week. He has a history of chronic obstructive pulmonary disease (COPD) and heart failure with preserved ejection fraction. The patient's brother is his legally appointed healthcare proxy, but the daughter is currently present and demands immediate aggressive interventions.

Upon arrival, a triage nurse accidentally administers 1 liter of 5% Dextrose in water (D5W) instead of the ordered isotonic saline. The daughter becomes furious upon realizing this and demands the nurse be fired immediately.

Temperature is 37.1°C (98.8°F), blood pressure is 115/75 mmHg, pulse is 105/min, and respirations are 16/min. Mucous membranes are dry, and he has diminished skin turgor. Neurologic examination reveals confusion and disorientation. Chest X-ray shows hyperinflated lungs. Lung auscultation reveals mild bilateral basilar crackles, which are unchanged from his baseline exams.

Laboratory studies are as follows:

TestResultReference Range
Hemoglobin8.9 g/dL13.5-17.5 g/dL
Leukocyte count6,500/mm³4,500-11,000/mm³
Platelet count180,000/mm³150,000-400,000/mm³
Serum calcium14.1 mg/dL8.4-10.2 mg/dL
Blood urea nitrogen48 mg/dL7-20 mg/dL
Serum creatinine2.5 mg/dL0.7-1.3 mg/dL
Total protein10.2 g/dL6.0-8.0 g/dL
Albumin3.4 g/dL3.5-5.5 g/dL
Thyroid-stimulating hormone (TSH)0.2 µU/mL0.4-4.0 µU/mL
Free T40.8 ng/dL0.9-1.7 ng/dL

A urine culture obtained two days ago at an outpatient clinic has just resulted, growing >100,000 CFU/mL of *Escherichia coli* that is sensitive to nitrofurantoin and cephalexin, but resistant to ampicillin.

Which of the following is the most appropriate next step in the management of this patient's acute condition?

Show answer & explanation

Answer: Initiation of aggressive intravenous isotonic saline hydration

Answer

The most appropriate next step in management is the initiation of aggressive intravenous isotonic saline hydration to treat the severe hypercalcemia.
The patient is presenting with a classic constellation of symptoms for multiple myeloma (hypercalcemia, renal failure, anemia, and bone pain). His severe hypercalcemia (14.1 mg/dL) is a medical emergency that causes osmotic diuresis, leading to profound volume depletion. The most critical initial step in managing severe hypercalcemia (>14 mg/dL) is aggressive intravenous hydration with isotonic saline. This rapidly restores intravascular volume, dilutes serum calcium, and promotes urinary calcium excretion.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and laboratory findings.
The patient has a large protein gap (Total protein 10.2 - Albumin 3.4 = 6.8 g/dL of globulins), normocytic anemia, acute kidney injury, bone pain, and severe hypercalcemia (14.1 mg/dL).
These combined findings are highly suggestive of Multiple Myeloma presenting with a hypercalcemic crisis.
2
Determine the immediate life-threatening physiological derangement.
Severe hypercalcemia (> 14 mg/dL) is causing the patient's acute lethargy, confusion, constipation, and severe volume depletion (dry mucous membranes, diminished turgor).
Hypercalcemia induces nephrogenic diabetes insipidus, leading to profound polyuria, systemic dehydration, and a vicious cycle of worsening hypercalcemia due to decreased renal calcium clearance.
3
Identify the standard first-line treatment for this oncologic emergency.
Aggressive intravenous hydration with isotonic saline is required.
Isotonic saline rapidly restores intravascular volume, dilutes serum calcium, and promotes loop of Henle calcium excretion, making it the most critical initial intervention.

Key Concept

The initial management of severe symptomatic hypercalcemia of malignancy requires immediate, aggressive intravenous hydration with isotonic saline to restore volume and increase renal calcium excretion.
Question 1184Question →

A 68-year-old man with a history of benign prostatic hyperplasia is admitted to the hospital with fever, severe left flank pain, and dysuria. His temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure is 100/60 mmHg100/60\text{ mmHg}, and heart rate is 110/min110\text{/min}. Laboratory studies show a leukocyte count of 18,000/mm318,000\text{/mm}^3. He is empirically started on intravenous piperacillin-tazobactam and intravenous fluids.

On hospital day 3, the patient is clinically improved and afebrile. Blood and urine cultures drawn at admission both grow *Enterobacter cloacae*.

Antimicrobial susceptibility testing of the isolate reveals the following:
- Ampicillin: Resistant
- Cefazolin: Resistant
- Ceftriaxone: Sensitive (MIC ≤1 μg/mL\leq 1\text{ }\mu\text{g/mL})
- Cefepime: Sensitive (MIC ≤1 μg/mL\leq 1\text{ }\mu\text{g/mL})
- Piperacillin-tazobactam: Sensitive (MIC 4 μg/mL4\text{ }\mu\text{g/mL})
- Meropenem: Sensitive (MIC ≤0.25 μg/mL\leq 0.25\text{ }\mu\text{g/mL})

Which of the following is the most appropriate next step in the antimicrobial management of this patient?

Show answer & explanation

Answer: Switch to intravenous cefepime

Answer

Switch to intravenous cefepime
The correct action is to switch to intravenous cefepime. This patient has a severe infection caused by *Enterobacter cloacae*, a member of the ESCPM group of organisms (which includes *Enterobacter*, *Serratia*, *Citrobacter freundii*, *Providencia*, and *Morganella*). These bacteria inherently possess an inducible chromosomal *ampC* beta-lactamase gene. When treated with a third-generation cephalosporin (such as ceftriaxone), subpopulations of bacteria that hyperproduce the AmpC enzyme are rapidly selected for, leading to high rates of clinical failure despite initial in vitro testing showing susceptibility. Cefepime, a fourth-generation cephalosporin, is highly stable against AmpC hydrolysis and is considered the drug of choice. It appropriately steps down the antimicrobial spectrum from the empiric piperacillin-tazobactam while ensuring a high likelihood of clinical success.

Step-by-Step Solution

1
Identify the pathogen and its specific intrinsic resistance mechanisms.
Enterobacter cloacae is identified, which is a classic AmpC beta-lactamase producing organism (part of the ESCPM group).
Accurate pathogen identification dictates the limitations of interpreting standard susceptibility reporting.
2
Evaluate the clinical risk of using third-generation cephalosporins for this isolate.
Ceftriaxone carries a high risk of inducing AmpC hyperproduction and failing clinically, despite appearing sensitive in vitro.
Exposure to third-generation cephalosporins selects for derepressed mutants, leading to rapid clinical failure.
3
Select the most appropriate targeted therapy based on antimicrobial stewardship principles.
Cefepime is selected because it is stable against AmpC hydrolysis and provides a narrower spectrum than carbapenems or piperacillin-tazobactam.
To successfully cure the infection while minimizing the selection pressure for broader resistance mechanisms.

Key Concept

Management of AmpC beta-lactamase-producing organisms (like Enterobacter) requires avoiding 3rd-generation cephalosporins (e.g., ceftriaxone) due to the high risk of inducible resistance; cefepime (a 4th-generation cephalosporin) or carbapenems are preferred.
Estimated Time:1m 30s
Question 1185Question →

A 76-year-old woman is evaluated in the hospital on day 5 of her admission due to an episode of hypotension and altered mental status. She was initially admitted for a severe COPD exacerbation and has been receiving systemic glucocorticoids, nebulized bronchodilators, and prophylactic enoxaparin. An indwelling Foley catheter was placed on admission due to urinary retention and has remained in place.

Today (Day 5), her temperature is 38.3∘C38.3^\circ\text{C} (100.9∘F100.9^\circ\text{F}), blood pressure is 88/56 mmHg88/56\text{ mmHg}, heart rate is 112/min112\text{/min}, and respiratory rate is 22/min22\text{/min}. Physical examination reveals a lethargic patient. The abdomen is soft and non-tender, and there is no costovertebral angle tenderness. Laboratory findings show a leukocyte count of 16,500/mm316,500\text{/mm}^3. A urinalysis obtained from the Foley catheter port shows 25 WBCs/hpf25\text{ WBCs/hpf} and positive leukocyte esterase, but negative nitrites.

Blood and urine cultures are drawn. The patient receives intravenous fluid resuscitation, and empiric intravenous vancomycin and cefepime are initiated.

Two days later (Day 7), the patient is clinically improved, her mental status has returned to baseline, she is hemodynamically stable off fluids, and she is afebrile. Blood cultures show no growth at 48 hours. The urine culture grows >105 CFU/mL>10^5\text{ CFU/mL} of *Enterococcus faecalis*.

Antimicrobial susceptibility testing for the *E. faecalis* isolate demonstrates the following:
- Ampicillin: Susceptible
- Cefepime: Resistant
- Ciprofloxacin: Resistant
- Linezolid: Susceptible
- Vancomycin: Susceptible

Which of the following is the most appropriate next step in the antimicrobial management of this patient?

Show answer & explanation

Answer: Discontinue vancomycin and cefepime, and initiate intravenous ampicillin

Answer

Discontinue vancomycin and cefepime, and initiate intravenous ampicillin
The correct answer is to discontinue vancomycin and cefepime, and initiate intravenous ampicillin. This patient presented with a catheter-associated urinary tract infection (CA-UTI) that progressed to sepsis. Her clinical improvement confirms successful empiric therapy. *Enterococcus* species are intrinsically resistant to cephalosporins (including cefepime). While her infection responded to vancomycin, continuing it when the isolate is susceptible to ampicillin violates antimicrobial stewardship principles. Ampicillin is a bactericidal beta-lactam and is the preferred, narrower-spectrum drug of choice for ampicillin-susceptible *E. faecalis*. De-escalating to ampicillin reduces the risk of selecting for vancomycin-resistant enterococci (VRE) and other highly resistant flora.

Step-by-Step Solution

1
Analyze the clinical presentation and initial course.
The patient developed sepsis (fever, hypotension, altered mental status, leukocytosis) due to a catheter-associated urinary tract infection (CA-UTI) and improved on empiric broad-spectrum therapy.
Establishes that this is a true, symptomatic infection requiring a full course of antimicrobial therapy, not merely asymptomatic bacteriuria.
2
Interpret the microbiological and susceptibility data.
The pathogen is *Enterococcus faecalis*. It is intrinsically resistant to cefepime, but susceptible to ampicillin, vancomycin, and linezolid.
Identifies the causative organism and the potential therapeutic options for targeted treatment.
3
Apply antimicrobial stewardship principles to select the optimal definitive therapy.
Ampicillin is selected to replace vancomycin and cefepime.
De-escalating to the narrowest-spectrum, most bactericidal agent (ampicillin) is the standard of care to maximize efficacy and prevent the emergence of vancomycin-resistant enterococci (VRE).

Key Concept

Antimicrobial stewardship in proven *Enterococcus faecalis* infections requires prompt de-escalation from empiric broad-spectrum agents (e.g., vancomycin) to a targeted, narrow-spectrum beta-lactam (e.g., ampicillin) if the isolate is susceptible.
Question 1186Question →

An emergency department physician evaluates a 62-year-old female patient reporting severe, progressively worsening mid-back pain over the past week. The pain is particularly severe in the supine position and frequently awakens her from sleep. Today, she developed bilateral lower extremity weakness and has been unable to urinate for the past 12 hours. Her medical history includes estrogen receptor-positive breast cancer, for which she underwent lumpectomy, radiation, and hormonal therapy five years ago.

Vital signs are within normal limits. Neurologic examination demonstrates 3/53/5 motor strength in both legs, decreased pain and temperature sensation below the umbilicus, and hyperreflexia at the patellar and Achilles tendons. Anal sphincter tone is diminished. Bladder ultrasound reveals a post-void residual volume of 600 mL600\text{ mL}.

Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Administer high-dose intravenous dexamethasone, 2) Obtain an urgent MRI of the entire spine, 3) Consult neurosurgery and radiation oncology, 4) Initiate definitive surgical decompression or radiotherapy.
Epidural spinal cord compression (ESCC) is an oncologic emergency. The initial management is immediate administration of high-dose corticosteroids (e.g., dexamethasone) to reduce vasogenic edema, alleviate pain, and prevent permanent neurologic injury. This step must not be delayed for imaging. Once steroids are administered, the next step is an urgent MRI of the entire spine to confirm the presence, level, and extent of the compression. Following MRI confirmation, consultation with neurosurgery and radiation oncology is obtained to formulate a definitive treatment plan, which ultimately culminates in surgical decompression and/or radiotherapy.

Step-by-Step Solution

1
Recognize the clinical presentation of epidural spinal cord compression (ESCC).
The patient's history of cancer, worsening back pain (especially supine), lower extremity weakness, sensory level, and bowel/bladder dysfunction strongly indicate ESCC.
Identifying the oncologic emergency is critical to initiating the time-sensitive management pathway.
2
Determine the immediate first step in management.
Intravenous dexamethasone is the first step.
Glucocorticoids decrease vasogenic edema surrounding the tumor and spinal cord, relieving pressure and potentially preserving or restoring neurologic function. This must be given before any diagnostic delays.
3
Select the optimal diagnostic imaging.
Urgent MRI of the entire spine is ordered.
MRI is required to visualize the epidural space, confirm the diagnosis, and check for multiple levels of compression (common in metastatic disease).
4
Determine the sequence for definitive treatment.
Surgical and radiation oncology consultations are obtained, leading to definitive decompression or radiation.
The anatomical details from the MRI guide the specialists in choosing between surgery (e.g., for spinal instability or radioresistant tumors) and radiotherapy.

Key Concept

In patients with suspected malignant epidural spinal cord compression, high-dose corticosteroids (dexamethasone) must be administered immediately upon clinical suspicion, prior to obtaining confirmatory imaging with an MRI of the spine.
Question 1187Question →

A female patient with a longstanding history of erosive polyarthritis and frequent episodes of podagra is brought to the emergency department by her family due to mucosal bleeding, diffuse bruising, and profound weakness. Three weeks prior, her rheumatologist discontinued her tumor necrosis factor inhibitor due to loss of efficacy and initiated a new oral disease-modifying antirheumatic drug. Her home medications also include a daily prophylactic agent to prevent her foot flares. Vital signs are within normal limits, though she appears pale and fatigued. Laboratory analysis reveals:

Laboratory TestResultReference Range
Hemoglobin6.5 g/dL6.5\text{ g/dL}12.0−16.0 g/dL12.0-16.0\text{ g/dL}
Leukocyte count1,100/μL1,100/\mu L4,500−11,000/μL4,500-11,000/\mu L
Absolute neutrophil count300/μL300/\mu L1,500−8,000/μL1,500-8,000/\mu L
Platelet count15,000/μL15,000/\mu L150,000−400,000/μL150,000-400,000/\mu L

Pharmacologic inhibition of which of the following enzymes most directly caused this patient's hematologic abnormalities?

Show answer & explanation

Answer: Xanthine oxidase

Answer

Xanthine oxidase
The correct answer is xanthine oxidase. This patient's presentation of profound pancytopenia (anemia, neutropenia, and thrombocytopenia) shortly after starting a new oral disease-modifying antirheumatic drug (DMARD) while taking a gout prophylactic agent is classic for azathioprine toxicity induced by an interaction with allopurinol or febuxostat. Azathioprine is metabolized into 6-mercaptopurine (6-MP), which exerts its immunosuppressive effects. 6-MP is inactivated through two primary pathways: thiopurine methyltransferase (TPMT) and xanthine oxidase. Because the patient is taking a xanthine oxidase inhibitor for recurrent gout flares, the primary degradation pathway of 6-MP is blocked. This causes a massive intracellular accumulation of active 6-MP metabolites (thioguanine nucleotides), which halt DNA synthesis in rapidly dividing cells, most notably leading to severe, life-threatening bone marrow suppression.

Step-by-Step Solution

1
Analyze the patient's medical history and current presentation.
The patient has rheumatoid arthritis (erosive polyarthritis) and gout (podagra) presenting with severe pancytopenia after starting a new oral DMARD.
Identifying the baseline diseases helps determine which medications the patient is taking.
2
Identify the likely home medications based on the history.
The daily prophylactic agent for podagra is a xanthine oxidase inhibitor (allopurinol or febuxostat).
Urate-lowering therapy is standard prophylaxis for frequent gout flares.
3
Determine the cause of the severe bone marrow suppression.
The pancytopenia is a consequence of a dangerous drug-drug interaction between the xanthine oxidase inhibitor and the new oral DMARD, azathioprine.
Azathioprine is a purine analog whose active metabolite (6-mercaptopurine) relies heavily on xanthine oxidase for degradation into inactive metabolites.
4
Link the mechanism to the correct enzyme.
The inhibition of xanthine oxidase by the gout medication directly blocked the metabolism of the azathioprine, causing fatal levels of active drug to accumulate.
This confirms the target enzyme asked for in the question.

Key Concept

Drug-drug interaction between azathioprine (a purine analog DMARD) and xanthine oxidase inhibitors (allopurinol or febuxostat), which prevents the degradation of 6-mercaptopurine and leads to life-threatening myelosuppression.
Question 1188Question →

A 68-year-old man with a history of chronic obstructive pulmonary disease (COPD) is hospitalized for induction chemotherapy for newly diagnosed acute myeloid leukemia. On day 8 of his admission, his absolute neutrophil count is 200/mm3200/\text{mm}^3 and his hemoglobin is 6.2 g/dL6.2\text{ g/dL}. He is afebrile and hemodynamically stable. He is prescribed a transfusion of two units of packed red blood cells.

Two hours into the transfusion, he develops acute-onset severe dyspnea, tachypnea, and a dry cough.

Vital signs are as follows:
- Temperature: 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F})
- Blood pressure: 178/92 mmHg178/92\text{ mmHg}
- Heart rate: 112/min112/\text{min}
- Respiratory rate: 26/min26/\text{min}
- SpO2\text{SpO}_2: 86%86\% on room air

Physical examination reveals a frail man in moderate respiratory distress using accessory muscles of respiration. Jugular venous pressure is 12 cm H2O12\text{ cm H}_2\text{O}. Chest auscultation reveals diffuse, prolonged expiratory wheezing with faint bibasilar crackles.

Arterial blood gas analysis on room air shows:
- pH: 7.287.28
- pCO2\text{pCO}_2: 56 mmHg56\text{ mmHg}
- pO2\text{pO}_2: 54 mmHg54\text{ mmHg}
- HCO3−\text{HCO}_3^-: 25 mEq/L25\text{ mEq/L}

Routine morning laboratory results (drawn prior to the transfusion) show:
- Sodium: 138 mEq/L138\text{ mEq/L}
- Potassium: 4.2 mEq/L4.2\text{ mEq/L}
- Chloride: 102 mEq/L102\text{ mEq/L}
- Bicarbonate: 24 mEq/L24\text{ mEq/L}
- Blood urea nitrogen: 18 mg/dL18\text{ mg/dL}
- Creatinine: 0.9 mg/dL0.9\text{ mg/dL}
- TSH: 0.2 μU/mL0.2\text{ }\mu\text{U/mL} (Normal: 0.4–4.00.4–4.0)
- Free T4: 0.7 ng/dL0.7\text{ ng/dL} (Normal: 0.9–1.70.9–1.7)

The transfusion is immediately halted, and the patient is placed on supplemental oxygen via a non-rebreather mask. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer intravenous furosemide

Answer

Administer intravenous furosemide
This patient is experiencing Transfusion-Associated Circulatory Overload (TACO). TACO is a hydrostatic pulmonary edema caused by a rapid increase in intravascular volume during a blood product transfusion, which overwhelms the cardiovascular system's compensatory mechanisms. It classically presents within 6 hours of transfusion with acute dyspnea, hypertension, tachycardia, and signs of volume overload such as elevated jugular venous pressure (JVP) and bibasilar crackles. The presence of wheezing in this patient is due to peribronchial edema (often termed 'cardiac asthma'), which can misleadingly suggest a primary airway disease like COPD. The immediate management of TACO includes halting the transfusion, providing respiratory support (supplemental oxygen or positive pressure ventilation), and administering intravenous loop diuretics like furosemide to rapidly reduce the intravascular volume overload.

Step-by-Step Solution

1
Analyze the patient's acute presentation in the context of an ongoing blood transfusion.
The patient developed acute respiratory distress, severe hypertension (178/92 mmHg178/92\text{ mmHg}), and elevated jugular venous pressure (12 cm H2O12\text{ cm H}_2\text{O}) within two hours of receiving blood products.
Identifying the hemodynamic status is crucial to differentiate between types of acute transfusion reactions, specifically TACO versus TRALI.
2
Differentiate Transfusion-Associated Circulatory Overload (TACO) from alternative pulmonary etiologies.
Hypertension and elevated JVP strongly indicate volume overload (TACO). The wheezing represents 'cardiac asthma' caused by peribronchial edema, not a primary COPD exacerbation.
Rapid intravascular volume expansion can precipitate acute hydrostatic pulmonary edema, especially in older patients or those receiving multiple units of blood.
3
Determine the most appropriate immediate pharmacological management.
Intravenous loop diuretics (e.g., furosemide) are indicated to promptly reduce intravascular volume and alleviate hydrostatic pulmonary edema.
Diuresis directly addresses the underlying pathophysiology of circulatory overload, complementing the immediate cessation of the transfusion and oxygen support.

Key Concept

Transfusion-Associated Circulatory Overload (TACO) is characterized by acute respiratory distress, severe hypertension, and signs of volume overload (elevated JVP, pulmonary edema) during or shortly after a transfusion. Immediate management requires halting the transfusion, providing respiratory support, and administering loop diuretics.
Estimated Time:2m 30s
Question 1189Question →

An 82-year-old woman who resides in a skilled nursing facility is brought to the clinic for a routine wellness visit. She has a history of mild vascular dementia and type 2 diabetes mellitus. The patient is at her baseline cognitive function and reports no fever, chills, dysuria, increased urinary urgency, or abdominal pain. Vital signs are temperature 37.0°C (98.6°F), blood pressure 138/82 mmHg, and pulse 78/min. The abdomen is non-tender and there is no costovertebral angle tenderness. As part of a general protocol by the nursing facility, a urinalysis and urine culture were obtained prior to the visit. The urinalysis shows moderate leukocyte esterase and positive nitrites. The urine culture grows >100,000 CFU/mL of Escherichia coli. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance and clinical observation

Answer

Reassurance and clinical observation
This patient has asymptomatic bacteriuria, defined as the presence of significant bacterial growth in the urine (typically >100,000 CFU/mL) without accompanying signs or symptoms of a urinary tract infection, such as dysuria, urgency, frequency, suprapubic pain, or fever. In most patient populations, including the elderly, patients with diabetes mellitus, and residents of long-term care facilities, asymptomatic bacteriuria is very common and does not lead to adverse outcomes like pyelonephritis or sepsis. Consequently, evidence-based guidelines recommend against screening for or treating asymptomatic bacteriuria in these groups. Treatment is exclusively reserved for specific high-risk populations, primarily pregnant women, patients undergoing mucosal urologic procedures, and recent renal transplant recipients. Because this patient falls into none of these high-risk categories, reassurance and clinical observation is the most appropriate management.

Step-by-Step Solution

1
Review the patient's clinical presentation and laboratory results.
The patient has a positive urine culture but no localizing genitourinary symptoms, systemic signs of infection, or altered mental status.
Establishing the presence or absence of symptoms is required to differentiate between a urinary tract infection and colonization.
2
Identify the primary diagnosis.
The diagnosis is asymptomatic bacteriuria (ASB).
ASB is defined as isolation of a specified quantitative count of bacteria in an appropriately collected urine specimen from a person without signs or symptoms referable to a urinary infection.
3
Determine the indication for antibiotic therapy based on guidelines.
Antibiotics are not indicated. Reassurance and observation is the correct approach.
Guidelines explicitly state that ASB should not be screened for or treated in the general elderly population, diabetics, or nursing home residents, as treatment does not improve outcomes and increases adverse events.

Key Concept

Management of asymptomatic bacteriuria in the elderly population.
Question 1190Question →

A 7878-year-old man who resides in a skilled nursing facility is evaluated for acute-onset severe pain and swelling in his right knee that began 2424 hours ago. He has a history of hypertension, diet-controlled type 2 diabetes mellitus, and advanced chronic kidney disease with a baseline serum creatinine of 2.6 mg/dL2.6 \text{ mg/dL}. Vital signs are within normal limits except for a temperature of 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}). Physical examination reveals a warm, erythematous, and swollen right knee with a moderate effusion. Range of motion is severely limited by pain. Arthrocentesis yields 4 mL4 \text{ mL} of cloudy, yellow synovial fluid. Analysis shows a leukocyte count of 32,000/μL32,000/\mu\text{L} with 90%90\% neutrophils. Polarized light microscopy demonstrates rhomboid-shaped crystals with weak positive birefringence. Gram stain reveals no organisms. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intra-articular triamcinolone injection

Answer

The correct answer is intra-articular triamcinolone injection.
This patient's presentation of an acutely painful, swollen joint with synovial fluid demonstrating rhomboid-shaped, positively birefringent crystals is diagnostic of an acute flare of calcium pyrophosphate deposition (CPPD) disease, commonly known as pseudogout. The synovial leukocyte count of 32,000/μL32,000/\mu\text{L} is consistent with an inflammatory arthritis. First-line treatments for acute CPPD flares typically include NSAIDs, oral colchicine, or intra-articular glucocorticoids. However, this patient has advanced chronic kidney disease (baseline creatinine 2.6 mg/dL2.6 \text{ mg/dL}). In this setting, NSAIDs are contraindicated due to the risk of precipitating acute renal failure, and colchicine is highly discouraged due to the risk of severe neuromyotoxicity and bone marrow suppression. Therefore, an intra-articular injection of a glucocorticoid (like triamcinolone) is the safest and most appropriate next step, providing targeted relief without systemic or renal toxicity.

Step-by-Step Solution

1
Interpret the synovial fluid analysis.
The fluid shows 32,000/μL32,000/\mu\text{L} leukocytes and rhomboid-shaped, positively birefringent crystals.
This confirms an acute flare of calcium pyrophosphate deposition (CPPD) disease (pseudogout) rather than septic arthritis.
2
Evaluate the patient's comorbidities for contraindications to standard therapies.
The patient has advanced chronic kidney disease (creatinine 2.6 mg/dL2.6 \text{ mg/dL}).
Standard first-line agents for pseudogout (NSAIDs and colchicine) are contraindicated or carry high toxicity risk in advanced renal impairment.
3
Select the safest and most effective targeted therapy.
Intra-articular glucocorticoid injection (e.g., triamcinolone) is chosen.
It provides excellent local anti-inflammatory effect while minimizing systemic absorption and avoiding renal toxicity.

Key Concept

Management of acute calcium pyrophosphate deposition (CPPD) disease flares involves avoiding NSAIDs and colchicine in patients with advanced chronic kidney disease, favoring intra-articular glucocorticoids.
Estimated Time:1m 0s
Question 1191Question →

A 68-year-old man with a history of metastatic prostate cancer presents to the emergency department with 2 days of progressively worsening lower back pain and new-onset bilateral leg weakness. He also reports difficulty initiating urination for the past 12 hours. Vital signs are within normal limits. Physical examination reveals reduced motor strength (3/5) in both lower extremities, hyperreflexia at the knees and ankles, and decreased sensation to pinprick below the umbilicus. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management for suspected malignant epidural spinal cord compression is to first administer intravenous dexamethasone, followed by obtaining an urgent MRI of the spine, and finally consulting neurosurgery and radiation oncology for definitive treatment.
This patient presents with classic signs of malignant epidural spinal cord compression (MESCC), a true oncologic emergency. The presence of back pain, motor weakness, hyperreflexia, and autonomic dysfunction (urinary retention) in a patient with a known malignancy requires immediate intervention. The absolute first step in management is the administration of intravenous dexamethasone to reduce vasogenic edema and protect the spinal cord from permanent ischemic damage. Once steroids are administered, an urgent MRI of the entire spine is indicated to definitively confirm the diagnosis and delineate the extent of the disease. Finally, with the MRI results available, consultation with neurosurgery and radiation oncology is necessary to plan definitive therapy, which typically involves surgical decompression or radiation.

Step-by-Step Solution

1
Identify the oncologic emergency based on clinical presentation.
The patient's history of metastatic prostate cancer, combined with back pain, lower extremity weakness, upper motor neuron signs (hyperreflexia), and autonomic dysfunction (urinary retention), strongly points to malignant epidural spinal cord compression (MESCC).
Early recognition of MESCC is crucial to prevent irreversible neurologic damage, such as permanent paraplegia.
2
Determine the immediate therapeutic intervention.
Administer high-dose intravenous dexamethasone immediately.
Corticosteroids decrease peritumoral vasogenic edema, quickly relieving pressure on the spinal cord. This must be given empirically upon clinical suspicion, before waiting for diagnostic imaging.
3
Determine the optimal diagnostic test.
Obtain an urgent magnetic resonance imaging (MRI) of the entire spine.
MRI is the gold standard modality to confirm the presence of cord compression, locate the exact level, and evaluate for synchronous asymptomatic lesions in the rest of the spine.
4
Determine the definitive care plan.
Consult neurosurgery and radiation oncology.
Once the diagnosis is confirmed and mapped by MRI, definitive therapy (surgical decompression and/or radiation therapy) is required depending on the patient's prognosis, tumor radiosensitivity, and spinal stability.

Key Concept

In a patient with suspected malignant epidural spinal cord compression, the administration of high-dose intravenous corticosteroids is the most critical first step and must precede confirmatory imaging with an MRI.
Question 1192Question →

A 68-year-old man is evaluated in the hospital on day 3 of admission for community-acquired pneumonia. His medical history is significant for hypertension and osteoarthritis. On admission, he presented with a temperature of 38.9°C (102.0°F), a productive cough, and a right lower lobe consolidation on chest radiography. He was started on empiric therapy with intravenous ceftriaxone and oral azithromycin.

Sputum and blood cultures obtained on admission have now finalized, both growing *Streptococcus pneumoniae*. Susceptibility testing of the isolate demonstrates the following:

AntimicrobialInterpretation
PenicillinSusceptible (MIC 0.03 mcg/mL)
AmoxicillinSusceptible
CeftriaxoneSusceptible
LevofloxacinSusceptible
AzithromycinResistant

Today, the patient reports feeling much better. He has been afebrile for the past 28 hours. His heart rate is 78/min, blood pressure is 128/82 mmHg, and respiratory rate is 16/min. Oxygen saturation is 96% on room air. He is tolerating a regular diet without difficulty. Which of the following is the most appropriate next step in his antimicrobial management?

Show answer & explanation

Answer: Transition to oral amoxicillin

Answer

Transition to oral amoxicillin
The correct decision is to transition to oral amoxicillin. This patient was initially treated appropriately with an empiric broad-spectrum regimen for community-acquired pneumonia. On day 3, he demonstrates excellent clinical improvement (afebrile for >24 hours, normalized vital signs, resolving symptoms) and is able to tolerate an oral diet. These factors fulfill the standard criteria for transitioning from intravenous to oral antibiotics. A fundamental principle of antimicrobial stewardship is 'de-escalation', which means narrowing the antibiotic spectrum as soon as a causative pathogen and its susceptibilities are known. Because the isolated *Streptococcus pneumoniae* is highly susceptible to penicillin, amoxicillin is the preferred narrow-spectrum, targeted oral agent.

Step-by-Step Solution

1
Assess the patient's clinical stability for transition from intravenous to oral therapy.
The patient is hemodynamically stable, afebrile for >24 hours, improving clinically, and tolerating an oral diet, making him a candidate for oral transition.
Transitioning to oral therapy reduces the risk of catheter-related complications and facilitates hospital discharge.
2
Review the finalized culture and susceptibility data.
Cultures demonstrate Streptococcus pneumoniae that is highly susceptible to penicillin and amoxicillin, but resistant to azithromycin.
Empiric broad-spectrum therapy must be tailored and narrowed once definitive culture data is available.
3
Select the most appropriate, narrow-spectrum oral agent.
Oral amoxicillin is selected.
Amoxicillin provides excellent targeted coverage for susceptible S. pneumoniae without the unnecessary broad-spectrum effects of levofloxacin or amoxicillin-clavulanate.

Key Concept

Clinically stable hospitalized patients with community-acquired pneumonia should be transitioned to a targeted, narrow-spectrum oral antibiotic (such as amoxicillin for susceptible S. pneumoniae) as soon as culture data permits and they are tolerating oral intake.
Question 1193Question →

A 24-year-old man presents to the clinic evaluating a 10-month history of insidious-onset lower back pain. He notes that the pain is worst upon awakening, is accompanied by profound stiffness lasting up to two hours, and significantly improves after physical activity. He has no other medical conditions and takes no medications. His vital signs are within normal limits. Physical examination reveals tenderness to palpation over the sacroiliac joints and reduced forward flexion of the lumbar spine (abnormal modified Schober test).

Arrange the following interventions in the correct chronological sequence for the standard diagnostic workup and stepwise medical management of this patient's suspected condition. Assume that initial diagnostic imaging is inconclusive (necessitating a more sensitive modality to confirm the diagnosis) and that the patient later requires escalation of maintenance therapy due to an inadequate clinical response to first-line pharmacotherapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain plain radiography of the sacroiliac joints, followed by MRI of the sacroiliac joints if X-rays are inconclusive. Once diagnosed, the first-line treatment is continuous scheduled NSAID therapy. If NSAIDs fail to provide adequate relief, the next step is escalation to a TNF-alpha inhibitor.
The standard evaluation for suspected axial spondyloarthritis begins with plain radiography of the sacroiliac (SI) joints. Because structural changes take years to develop, X-rays may initially be normal. In cases of high clinical suspicion with negative X-rays, MRI of the SI joints is the next step to detect active inflammation (bone marrow edema). Once the diagnosis is secured, the absolute first-line pharmacologic treatment is a continuous nonsteroidal anti-inflammatory drug (NSAID) trial (along with physical therapy). If the patient remains symptomatic after an adequate trial (e.g., at least two different NSAIDs over 4 weeks), therapy is escalated to a biologic agent, most commonly a tumor necrosis factor (TNF) alpha inhibitor such as adalimumab or etanercept.

Step-by-Step Solution

1
Identify the suspected diagnosis based on the clinical presentation.
The patient has insidious-onset inflammatory back pain (morning stiffness > 1 hour, improves with activity, young age of onset), strongly suggesting axial spondyloarthritis (ankylosing spondylitis).
Recognizing the classic presentation of inflammatory back pain dictates the specific diagnostic and management algorithm to follow.
2
Determine the initial diagnostic imaging modality.
Plain radiography of the sacroiliac joints should be ordered first.
Plain X-ray is the standard initial imaging test to evaluate for definitive structural changes (e.g., erosions, sclerosis, or joint fusion).
3
Determine the appropriate secondary diagnostic test when initial imaging is inconclusive.
MRI of the sacroiliac joints is ordered next.
Because plain radiographs are often normal early in the disease course, MRI is highly sensitive for detecting active bone marrow edema (early sacroiliitis) and confirming non-radiographic axial spondyloarthritis.
4
Identify the first-line pharmacologic treatment once the diagnosis is confirmed.
Continuous scheduled therapy with an NSAID is initiated.
NSAIDs are the cornerstone of initial medical management for axial spondyloarthritis and must be optimized before considering biologic therapies.
5
Determine the next step in management if first-line therapy is ineffective.
Escalate to a TNF-alpha inhibitor.
Patients with persistently high disease activity despite an adequate trial of continuous NSAIDs should be treated with a biologic agent, such as a TNF-alpha or IL-17 inhibitor.

Key Concept

The diagnostic and therapeutic stepwise approach to axial spondyloarthritis.
Question 1194Question →

An adult female patient is evaluated in the acute care clinic approximately 11 hour following the intentional ingestion of a large, unknown quantity of acetaminophen. On initial assessment, she is fully alert, cooperative, and reports no symptoms. Hemodynamic parameters are stable. Arrange the following clinical interventions in the most appropriate chronological sequence for the evaluation and treatment of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: (1) Perform gastrointestinal decontamination with activated charcoal, (2) Measure serum acetaminophen concentration at 44 hours post-ingestion, (3) Assess the hepatotoxicity risk using the Rumack-Matthew nomogram, (4) Initiate targeted N-acetylcysteine (NAC) therapy if indicated.
The evaluation of acute acetaminophen overdose relies strictly on the time elapsed since ingestion. For a patient presenting early (at 11 hour), gastrointestinal decontamination with activated charcoal is the first priority to limit further absorption. Next, standard toxicology guidelines dictate that serum acetaminophen levels must not be drawn until exactly 44 hours post-ingestion, as earlier levels do not reflect peak systemic concentrations. Once the 44-hour level is resulted, it is immediately plotted on the Rumack-Matthew nomogram. Finally, N-acetylcysteine (NAC) is initiated only if the level lies on or above the treatment line. Because the patient presented so early, this sequential diagnostic evaluation can be safely completed well before the critical 88-hour mark, when NAC begins to lose its maximal hepatoprotective efficacy.

Step-by-Step Solution

1
Evaluate the timeline for safe gastrointestinal decontamination.
Because the ingestion occurred only 11 hour ago and the patient is alert, activated charcoal should be administered first.
Charcoal is highly effective at binding unabsorbed drug in the stomach if given within the first 22 hours.
2
Determine the optimal timing for initial laboratory evaluation.
The clinician must wait until the 44-hour mark to draw a serum acetaminophen level.
Levels obtained before 44 hours represent incomplete absorption and cannot reliably predict toxicity.
3
Analyze the laboratory data for clinical decision-making.
The 44-hour level is plotted on the Rumack-Matthew nomogram.
This visual tool correlates serum concentration with time to definitively predict the likelihood of severe liver injury.
4
Decide on definitive antidote administration.
NAC is prescribed only if the plotted level crosses the treatment line.
This sequential approach prevents unnecessary treatment while ensuring full hepatoprotection, since the decision occurs well within the 88-hour maximal therapeutic window.

Key Concept

Chronological management and risk stratification of acute acetaminophen toxicity
Question 1195Question →

Match each patient's clinical presentation with the most appropriate first-line pharmacotherapy.

Click a left item, then click its matching right item

Items

A 24-year-old man with a painless penile ulcer with indurated margins and non-tender inguinal lymphadenopathy.
A 22-year-old woman with a frothy, yellow-green vaginal discharge and punctate cervical hemorrhages.
A 26-year-old man with purulent urethral discharge; Gram stain shows intracellular Gram-negative diplococci.
A 21-year-old woman with mucopurulent cervicitis; nucleic acid amplification testing (NAAT) is positive for an obligate intracellular bacterium.

Matches

Show answer & explanation

Answer

The correct pairings are: Primary syphilis with Intramuscular penicillin G benzathine; Trichomoniasis with Oral metronidazole; Gonorrhea with Intramuscular ceftriaxone; Chlamydia with Oral doxycycline.
Each classic presentation of a sexually transmitted infection uniquely matches with its standard, guideline-directed monotherapy. Recognizing the hallmark signs (e.g., painless ulcer for syphilis, intracellular diplococci for gonorrhea) allows for the direct selection of the appropriate antibiotic.

Step-by-Step Solution

1
Identify the underlying infectious etiology for the first clinical presentation.
A painless penile ulcer indicates primary syphilis.
Syphilis classically presents as a painless chancre, requiring penicillin therapy.
2
Identify the underlying infectious etiology for the second clinical presentation.
Frothy, yellow-green discharge and punctate cervical hemorrhages ('strawberry cervix') indicate Trichomonas vaginalis infection.
These are the classic hallmark findings for trichomoniasis, which is treated with antiprotozoal agents.
3
Identify the underlying infectious etiology for the third clinical presentation.
Purulent discharge with intracellular Gram-negative diplococci indicates Neisseria gonorrhoeae infection.
Gonococcus uniquely appears as Gram-negative diplococci inside polymorphonuclear leukocytes.
4
Identify the underlying infectious etiology for the fourth clinical presentation.
Mucopurulent cervicitis caused by an obligate intracellular bacterium indicates Chlamydia trachomatis.
Chlamydia cannot synthesize its own ATP and relies on the host cell, requiring targeted antibiotic therapy.
5
Match each identified pathogen to its guideline-directed medical therapy.
Syphilis -> Penicillin G; Trichomonas -> Metronidazole; Gonorrhea -> Ceftriaxone; Chlamydia -> Doxycycline.
Applying standard pharmacological guidelines ensures appropriate antimicrobial coverage and stewardship.

Key Concept

First-line pharmacotherapy for common sexually transmitted infections (STIs)
Question 1196Question →

A 61-year-old man is brought to the emergency department due to a three-day history of progressively worsening breathlessness, orthopnea, and a cough productive of clear sputum. His past medical history is significant for severe chronic obstructive pulmonary disease (COPD), ischemic cardiomyopathy with a left ventricular ejection fraction of 35%35\%, and diet-controlled type 2 diabetes mellitus. Vital signs show a temperature of 37.1∘37.1^\circ C (98.8∘98.8^\circ F), pulse of 112/min, blood pressure of 155/92 mm Hg, and respiratory rate of 26/min. Pulse oximetry demonstrates an oxygen saturation of 86%86\% on room air. Physical examination reveals neck veins distended to 11 cm H2OH_2O while the patient is seated at a 45-degree angle. Auscultation of the lungs demonstrates prominent bibasilar crackles without any wheezing. Cardiac examination reveals a regular tachycardia and an S3S_3 gallop. The lower extremities exhibit 2+2+ pitting edema bilaterally.

Laboratory results are as follows:

TestResult
Leukocyte count8,200/mm38,200/\text{mm}^3
Serum sodium136 mEq/L
Serum potassium4.1 mEq/L
Serum chloride99 mEq/L
Serum bicarbonate29 mEq/L
Blood urea nitrogen32 mg/dL
Serum creatinine1.4 mg/dL
TSH0.2 mU/L (Normal: 0.5-5.0)
Free T4T_40.7 ng/dL (Normal: 0.9-1.7)

An arterial blood gas on room air shows a pH of 7.26, a PaCO2PaCO_2 of 65 mm Hg, and a PaO2PaO_2 of 52 mm Hg.

Which of the following is the most appropriate initial pharmacological step in the management of this patient?

Show answer & explanation

Answer: Administer intravenous furosemide

Answer

The most appropriate initial pharmacological step is to administer intravenous furosemide to aggressively manage the acute decompensated heart failure.
This patient presents with classic signs of acute decompensated heart failure (ADHF), including orthopnea, elevated jugular venous pressure (11 cm H2OH_2O), an S3S_3 gallop, bibasilar crackles without wheezing, and peripheral edema. Despite his history of COPD, the specific clinical signs (particularly the S3S_3 gallop and lack of wheezing) indicate that cardiogenic pulmonary edema is the primary cause of his acute respiratory failure. The cornerstone of initial pharmacological management for volume overload in ADHF is intravenous loop diuretics, such as furosemide, which rapidly reduce preload, decrease pulmonary capillary wedge pressure, and relieve pulmonary congestion.

Step-by-Step Solution

1
Analyze the physical examination findings.
The patient has an elevated jugular venous pressure, bibasilar crackles without wheezing, an S3S_3 gallop, and pitting edema.
These findings strongly differentiate acute decompensated heart failure (cardiogenic pulmonary edema) from a COPD exacerbation.
2
Evaluate the arterial blood gas and basic metabolic panel.
The ABG reveals a primary respiratory acidosis (pH 7.26, PaCO2PaCO_2 65 mm Hg) with a partially elevated bicarbonate (29 mEq/L).
This indicates an acute-on-chronic respiratory acidosis typical for a patient with baseline COPD who is acutely hypoventilating due to severe pulmonary edema.
3
Assess the thyroid function tests.
TSH and Free T4T_4 are both low in the setting of severe acute illness.
This pattern is characteristic of euthyroid sick syndrome (non-thyroidal illness syndrome), which requires observation rather than hormone replacement.
4
Determine the optimal therapeutic intervention.
Administer intravenous loop diuretics (e.g., furosemide).
Rapid preload reduction is required to alleviate pulmonary congestion and improve oxygenation in acute decompensated heart failure.

Key Concept

Differentiating acute decompensated heart failure from COPD exacerbations clinically, while recognizing euthyroid sick syndrome and appropriate acid-base compensation patterns in acutely ill patients.
Question 1197Question →

A 62-year-old woman is evaluated for progressively worsening fatigue and dyspnea on exertion over the past 3 months. She has followed a strict vegan diet for the past 5 years and does not take any nutritional supplements. Physical examination reveals pale conjunctivae, a smooth and red tongue, and decreased vibratory sensation in the lower extremities bilaterally. Laboratory studies show:

TestResultReference Range
Hemoglobin9.2 g/dL12.0-15.5 g/dL
Mean corpuscular volume114 fL80-100 fL

Which of the following additional laboratory findings is most likely to be present in this patient?

Show answer & explanation

Answer: Elevated methylmalonic acid and elevated homocysteine

Answer

Elevated methylmalonic acid and elevated homocysteine
The patient's strict vegan diet, macrocytic anemia (MCV > 100 fL), glossitis, and neurologic symptoms (decreased vibratory sensation) are classic for vitamin B12 (cobalamin) deficiency. Vitamin B12 is a required cofactor for two major reactions: the conversion of methylmalonyl-CoA to succinyl-CoA and the conversion of homocysteine to methionine. Therefore, a deficiency in vitamin B12 leads to the accumulation and elevated serum levels of both methylmalonic acid and homocysteine.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and diet history.
The patient has fatigue, a strict vegan diet, glossitis (smooth, red tongue), and neurologic symptoms (decreased vibratory sensation).
Identifying the clinical syndrome helps narrow down the etiology of the anemia.
2
Interpret the initial laboratory findings.
Hemoglobin is low (9.2 g/dL) and MCV is elevated (114 fL), indicating a macrocytic anemia.
Macrocytic anemias are commonly caused by vitamin B12 or folate deficiency, liver disease, or alcohol use.
3
Differentiate between the causes of macrocytic anemia based on symptoms.
The presence of neurologic symptoms (decreased vibratory sensation) points to vitamin B12 deficiency rather than folate deficiency.
Vitamin B12 is essential for myelin synthesis, and its deficiency leads to subacute combined degeneration of the spinal cord.
4
Determine the expected confirmatory laboratory findings.
Vitamin B12 deficiency results in the elevation of both methylmalonic acid and homocysteine.
Vitamin B12 is a cofactor for the conversion of methylmalonyl-CoA to succinyl-CoA and homocysteine to methionine.

Key Concept

Patients with a strict vegan diet are at risk for vitamin B12 deficiency, which presents with macrocytic anemia, glossitis, and neurologic deficits, and is confirmed by elevated levels of both methylmalonic acid and homocysteine.
Question 1198Question →

Match each clinical presentation involving the hands and joints to the most likely rheumatologic diagnosis.

Click a left item, then click its matching right item

Items

A 42-year-old man with asymmetric oligoarthritis, dactylitis, and radiographic evidence of erosions with bone proliferation at the distal interphalangeal joints
A 65-year-old woman with chronic hand pain that worsens with use, squaring of the first carpometacarpal joint, and palpable bony nodules at the distal interphalangeal joints
A 40-year-old woman with progressive proximal muscle weakness and violaceous, scaly plaques symmetrically distributed over the metacarpophalangeal and interphalangeal joints
A 50-year-old woman with symmetric polyarthritis of the hands, morning stiffness lasting 2 hours, and fixed ulnar deviation of the metacarpophalangeal joints
A 48-year-old woman with long-standing Raynaud phenomenon, esophageal dysmotility, and skin thickening restricted to the fingers and hands

Matches

Show answer & explanation

Answer

The correct matches link dactylitis and distal interphalangeal joint erosions to psoriatic arthritis; Heberden nodes and first carpometacarpal squaring to osteoarthritis; proximal weakness and Gottron papules to dermatomyositis; symmetric polyarthritis with ulnar deviation to rheumatoid arthritis; and Raynaud phenomenon with sclerodactyly to limited cutaneous systemic sclerosis.
Each clinical presentation highlights high-yield manifestations of specific rheumatologic diseases affecting the hands. Diagnosis relies on combining joint distribution (e.g., distal vs. proximal), the character of stiffness (inflammatory vs. non-inflammatory), and unique cutaneous or radiographic findings (Gottron papules, sclerodactyly, dactylitis).

Step-by-Step Solution

1
Analyze the joint distribution in each vignette.
Identified involvement of distal interphalangeal joints (osteoarthritis, psoriatic arthritis) versus metacarpophalangeal/proximal interphalangeal joints (rheumatoid arthritis, dermatomyositis skin findings).
Different rheumatologic conditions have predictable and distinct patterns of joint involvement.
2
Evaluate the character of symptoms (inflammatory vs. non-inflammatory).
Recognized prolonged morning stiffness in the 50-year-old woman as inflammatory (rheumatoid arthritis), and activity-related pain in the 65-year-old woman as non-inflammatory (osteoarthritis).
Differentiating osteoarthritis from inflammatory arthritides is a critical step in rheumatologic diagnosis.
3
Identify pathognomonic physical exam and radiographic findings.
Matched Gottron papules to dermatomyositis, sclerodactyly to systemic sclerosis, and dactylitis with erosive bone proliferation to psoriatic arthritis.
These specific extra-articular and radiographic findings definitively differentiate systemic autoimmune conditions with overlapping features.

Key Concept

Clinical presentation and joint distribution of rheumatologic diseases
Question 1199Question →

A 54-year-old man comes to the office due to worsening redness and swelling of his left lower leg over the past 48 hours. He reports no fever, chills, or systemic symptoms. His medical history includes hypertension and diet-controlled type 2 diabetes mellitus. Vital signs show a temperature of 37.2°C (99.0°F), blood pressure of 130/80 mm Hg, and heart rate of 78/min. Physical examination of the left lower extremity reveals a 10-cm area of poorly demarcated erythema, warmth, and tenderness over the anterior shin. There is no fluctuance, purulent drainage, or palpable fluid collection. Which of the following is the most appropriate antibiotic therapy?

Show answer & explanation

Answer: Oral cephalexin

Answer

Oral cephalexin
The patient presents with classic signs of mild, non-purulent cellulitis (poorly demarcated erythema, warmth, tenderness) without systemic toxicity or signs of an abscess (no fluctuance or purulence). The most common pathogens responsible for non-purulent cellulitis are beta-hemolytic streptococci (e.g., Streptococcus pyogenes) and methicillin-susceptible Staphylococcus aureus (MSSA). Oral cephalexin (a first-generation cephalosporin) provides excellent targeted coverage for these organisms and is a standard first-line treatment for uncomplicated cases.

Step-by-Step Solution

1
Identify the clinical syndrome based on the physical examination.
The patient has localized erythema, warmth, and tenderness without fluctuance or purulence, indicating mild non-purulent cellulitis.
Differentiating purulent from non-purulent skin infections dictates the likely pathogens and the appropriate antibiotic coverage.
2
Determine the most likely causative organisms.
Beta-hemolytic streptococci (e.g., Streptococcus pyogenes) and methicillin-susceptible Staphylococcus aureus (MSSA) are the primary pathogens.
Non-purulent cellulitis is overwhelmingly caused by beta-hemolytic streptococci, whereas purulent infections are more commonly associated with Staphylococcus aureus (including MRSA).
3
Select the appropriate targeted antimicrobial therapy.
Oral cephalexin provides excellent coverage for both beta-hemolytic streptococci and MSSA.
For mild infections without systemic signs (such as high fever or tachycardia), narrow-spectrum oral therapy is preferred, following principles of antibiotic stewardship.

Key Concept

Mild, non-purulent cellulitis is primarily caused by beta-hemolytic streptococci and should be treated with targeted, narrow-spectrum oral antibiotics such as cephalexin, dicloxacillin, or penicillin.
Question 1200Question →

A 34-year-old unhoused man is brought to the emergency department by paramedics after being found in severe distress in an alleyway. He sustained a deep puncture wound to his right sole from a rusty metal fence approximately 8 days ago. He has no known medical history, and his childhood vaccination status is unknown. On arrival, he is diaphoretic, tachycardic to 122/min, and tachypneic to 26/min. Physical examination reveals profound trismus, a sustained grimace of the facial muscles, and episodic, painful spasms of the paraspinal musculature that are immediately triggered by the noise of a dropping tray in the trauma bay. The right foot shows a 3-cm deep, purulent puncture wound surrounded by necrotic tissue.

Arrange the following therapeutic interventions in the most appropriate chronological sequence for the management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first stabilize the patient by securing the airway and administering intravenous diazepam, followed by administering HTIG to neutralize unbound toxin, then performing surgical debridement of the wound, and finally administering the Tdap vaccine for long-term immunity.
The management of severe clinical tetanus dictates a strict chronological hierarchy: 1) Resuscitation and supportive care (Airway, low-stimulus environment, GABA-agonists like diazepam) to prevent acute asphyxiation. 2) Toxin neutralization (HTIG) to bind circulating tetanospasmin before it undergoes retrograde axonal transport. 3) Source control (Surgical debridement and antibiotics) to eliminate the anaerobic environment producing the toxin; this strictly follows HTIG so that any toxin released during surgery is immediately neutralized. 4) Active immunization (Tdap vaccine) because the disease itself does not confer lasting immunity.

Step-by-Step Solution

1
Prioritize immediate life-saving stabilization (ABCs).
Secure the airway, minimize environmental stimuli, and administer intravenous diazepam.
The most imminent threat to life in generalized clinical tetanus is respiratory failure from diaphragmatic rigidity and laryngospasm. Benzodiazepines act as GABA agonists to control these muscle spasms.
2
Provide passive immunity to halt disease progression.
Administer intramuscular human tetanus immune globulin (HTIG).
HTIG neutralizes unbound, circulating tetanospasmin. Once the toxin enters the presynaptic terminals of inhibitory motor neurons, it is no longer accessible to antibodies. Therefore, early administration is critical.
3
Achieve source control to stop further toxin production.
Perform extensive surgical debridement of the infected wound.
Debridement removes necrotic tissue and spores. This step MUST follow HTIG administration, as the physical manipulation of the wound can release a massive surge of pre-formed toxin into the systemic circulation.
4
Establish active, long-term immunity.
Administer the Tdap (Tetanus, diphtheria, and acellular pertussis) vaccine.
Because the lethal dose of tetanus toxin is far below the threshold required to trigger an adaptive immune response, resolving the infection does not confer natural immunity. Patients must receive the active vaccine series.

Key Concept

Management Sequence of Generalized Tetanus
Estimated Time:2m 0s
PreviousPage 60 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 60 | Examkin